Increased adiposity significantly impacts women's reproductive health, leading to reduced fertility, heightened risks of polycystic ovarian syndrome (PCOS), and irregular ovulation. Overweight individuals with PCOS face elevated susceptibility to insulin resistance and potential development of diabetes. These factors contribute to the complexity and reduced success of infertility treatments. Furthermore, the association between obesity and menstrual/ovarian disorders heightens the likelihood of ovarian, endometrial, and breast cancers, with the prevalence of gynecological cancers escalating alongside higher body mass index (BMI).